A skin-mimetic silicone surface that combines covalently grafted, printed hydrophilic domains with a hydrophobic, skin-textured thiol-ene matrix. It reproduces how skin pins fluids and resists dewetting while maintaining skin-like friction and durability. Suitable for skin simulants, product testing substrates, and applications requiring long-lasting, skin-like fluid handling.
This technology is a photo-cured silicone material engineered to mimic the wetting behavior of human skin. Real skin is neither uniformly hydrophilic nor uniformly hydrophobic – it pins fluids through a combination of surface chemistry patches and micro-scale furrows. This silicone reproduces that behavior by creating sparse, covalently bonded hydrophilic domains on a hydrophobic, skin-textured silicone matrix. The result is a surface on which drops do not readily roll or spread, closely matching the behavior of fluids on skin, while preserving skin-like friction and avoiding the slippery, fully hydrated surfaces of continuous hydrogels.
The approach is intended for use in skin simulants, in vitro testing substrates, consumer-product evaluation, and any application needing durable, skin-like fluid handling. Because the hydrophilic domains are covalently grafted and printed in precise registration with the surface texture, the wetting behavior is designed to persist through rubbing, cleaning, and accelerated ageing.
How it works:
Key features:
The technology is in an active research and development phase. A 12-month program is planned that will screen domain size, coverage, and depth for target fluids, then validate durability through rubbing, cleaning, accelerated and light-exposed ageing, extractables testing, and tack measurements. The final stage will produce reproducible coupons with standard operating procedures, quality-control specifications, and real-time ageing data. An optional extension includes a second optimization loop, a 50-coupon pilot batch, and 12 months of additional real-time data. Interim coupons are expected to support early pre-screening within six months.